Expert Guidance on the Optimal Use of Current and Emerging BTK Inhibitors for Patients with CLL_Matthew Davids, MD, MMSc
41:32
Chronic Lymphocytic Leukemia
Expert Guidance on the Optimal Use of Current and Emerging BTK Inhibitors for Patients with CLL_Matthew Davids, MD, MMSc
Chronic Lymphocytic Leukemia Similar Videos
Similar Videos
-
Module 4: Emerging BTK Inhibitors_Matthew Davids, MD, MMSc_Catherine Coombs, MD_Anthony Mato, MD, MSCE
12:02
-
Susan O’Brien, MD; University of California Irvine; #DDHO2022
20:24
-
Recently presented data and optimal therapeutic approaches in relapsed/refractory CLL_Jennifer Brown, MD, PhD; #BeyondASCO
13:52
